...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017

Re: Resverlogix Files 2017 Year-End Disclosure Documents and Announces Plans to Host a Symposium at the European Society of Cardiology Congress 2017

posted on Jul 26, 2017 04:03PM

,,,nor does whats in DMs' head matter as far as what he thinks RVX is worth,,,its what the buyer inner is willing to put forth!!,,,It must be assumed what ever the mix of financial support we get is already a done deal. When you schedule an update the day before a major financial burden is due one would think the ducks have been lined up.

Our share price seems to be supported here by third world bamboo staging at the moment. We cant get traction to move higher. It is well known biotech is speculative but that does not prevent lofty valuations on other higher speculative plays. Maybe it is all hinged around the expected dilution, whether it be small or large its an unknown which the market is willing to wait on. It would be nice of course to have the FA succeed and behind us before the Aug 28th. One will need nerves of steel in the coming weeks,,,,,,,,,,,,,jmo

Share
New Message
Please login to post a reply